Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases

Clinical trial NCT01852370 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT01852370
Sponsor: Paul Szabolcs
Status: ENROLLING_BY_INVITATION
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Severe Combined Immunodeficiency (SCID)Immunodeficiency With Predominant T-cell Defect, Unspecified Severe Chronic Neutropenia Chronic Granulomatous Disease (CGD)Hyper IgE Syndromes Hyper IgM Deficiencies Wiskott-Aldrich Syndrome Mendelian Susceptibility to Mycobacterial Disease Common Variable Immune Deficiency (CVID)

Start date: 2013-06-20
Primary completion: 2026-11-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.